R. Arıkan Et Al. , "Rechallenge with dabrafenib plus trametinib in anaplastic thyroid cancer: A case report and review of literature," CURRENT PROBLEMS IN CANCER , vol.45, no.2, 2021
Arıkan, R. Et Al. 2021. Rechallenge with dabrafenib plus trametinib in anaplastic thyroid cancer: A case report and review of literature. CURRENT PROBLEMS IN CANCER , vol.45, no.2 .
Arıkan, R., Telli, T., Demircan, N., Başoğlu, T., Ercelep, Ö., Atasoy, B. M., ... Özgüven, S.(2021). Rechallenge with dabrafenib plus trametinib in anaplastic thyroid cancer: A case report and review of literature. CURRENT PROBLEMS IN CANCER , vol.45, no.2.
Arıkan, R Et Al. "Rechallenge with dabrafenib plus trametinib in anaplastic thyroid cancer: A case report and review of literature," CURRENT PROBLEMS IN CANCER , vol.45, no.2, 2021
Arıkan, R Et Al. "Rechallenge with dabrafenib plus trametinib in anaplastic thyroid cancer: A case report and review of literature." CURRENT PROBLEMS IN CANCER , vol.45, no.2, 2021
Arıkan, R. Et Al. (2021) . "Rechallenge with dabrafenib plus trametinib in anaplastic thyroid cancer: A case report and review of literature." CURRENT PROBLEMS IN CANCER , vol.45, no.2.
@article{article, author={R Arıkan Et Al. }, title={Rechallenge with dabrafenib plus trametinib in anaplastic thyroid cancer: A case report and review of literature}, journal={CURRENT PROBLEMS IN CANCER}, year=2021}